Loews stock performance snapshot after recent moves

Loews (L) has seen mixed short term performance, with the stock up 0.6% over the past day and 1.2% over the past week, while declining about 5.0% over the past month.

Over the past 3 months, Loews is down roughly 2.7%. Its 1 year total return sits near 18.7%, with a 3 year total return around 82% and a 5 year total return close to 87%.

At a share price of $105.80, Loews has recently given back some ground over the past month even as its 1 year total shareholder return remains positive. This suggests that short term momentum is fading while longer term holders have still seen gains.

If you are comparing Loews with other opportunities in the market, this could be a good moment to broaden your search and check out 19 top founder-led companies

With Loews trading near $105.80 and an intrinsic value estimate that is modestly higher, the key question is whether you are seeing a genuine discount or if the stock already reflects its diversified insurance, pipelines, hotels, and plastics businesses. Is there still a buying opportunity here, or is the market already pricing in expectations for the company?

Price-to-Earnings of 13.3x: Is it justified?

Loews trades on a P/E of 13.3x, while the stock sits around $105.80 and screens as slightly below some fair value and cash flow estimates in the data provided.

The P/E ratio compares the share price to earnings per share and is a common way investors gauge how much they are paying for current profits. For a diversified insurer with exposure to pipelines, hotels and plastics, this metric can help you sense what the market is willing to pay for its earnings profile right now.

Loews is described as expensive on a P/E of 13.3x versus both the US insurance industry average of 11.1x and a peer group average of 11.4x. That gap suggests investors are paying a premium relative to sector and peers, which can sometimes reflect confidence in earnings quality and profit trends, but it also leaves less room if sentiment cools.

Result: Price-to-Earnings of 13.3x (OVERVALUED)

However, you should also weigh risks such as insurance underwriting losses or weaker results from hotels and pipelines, which could challenge the current valuation story.

Another view: cash flows suggest a slight discount

While the P/E of 13.3x makes Loews look expensive versus insurers and peers, the SWS DCF model points in a different direction. At $105.80 per share versus an estimated future cash flow value of $111.25, the stock screens as roughly 4.9% undervalued. Which signal do you trust more: earnings or cash flows?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Loews for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 51 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Seen enough to sense both optimism and caution in this story? Act while the data is fresh in your mind, carefully weigh the trade offs, and check the 2 key rewards and 1 important warning sign

Looking for more investment ideas?

If you stop with just one stock, you could miss out on opportunities that fit your risk comfort, income goals, and growth expectations across the rest of your portfolio.

• Supercharge your search for potential bargains by scanning 51 high quality undervalued stocks that pair solid fundamentals with prices that may sit below fair value estimates.
• Strengthen your income stream by checking 13 dividend fortresses that focus on stocks offering yields of 5% or more with an emphasis on stability.
• Protect your downside by reviewing 65 resilient stocks with low risk scores that highlight companies with lower risk scores so you can aim for steadier outcomes.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.